$10.12
-0.28 (-2.69%)
Performance
1D
—
1W
—
1M
—
3M
-15.74%
6M
+328.81%
1Y
+628.06%
YTD
+181.89%
Open$10.47
Previous Close$10.40
Day High$10.54
Day Low$9.94
52W High$24.28
52W Low$1.06
Volume—
Avg Volume13.66M
Market Cap3.23B
P/E Ratio—
EPS$-0.44
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$7.48
Above
SMA 200
$3.25
Above
RSI (14)
71.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+143.6% upside
Current
$10.12
$10.12
Target
$24.65
$24.65
$19.75
$24.65 avg
$31.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.62M | 918.48M | 827.43M |
| Net Income | -100,463,137 | -95,918,574 | -115,001,691 |
| Profit Margin | -11.2% | -10.4% | -13.9% |
| EBITDA | -104,291,949 | -115,509,109 | -110,721,792 |
| Free Cash Flow | -130,963,293 | -137,514,931 | -125,568,165 |
| Rev Growth | +16.3% | +1.8% | +8.3% |
| Debt/Equity | 0.25 | 0.25 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |